Caffeine is known to decrease vasodilation and have immunosuppressant effects, which may potentially decrease the risk of rosacea. However, the heat from coffee may be a trigger for rosacea flares. The relationship between the risk of rosacea and caffeine intake, including coffee consumption, is poorly understood.
R osacea is a common chronic inflammatory skin disease. 1, 2 Many triggers for rosacea have been postulated, including caffeine, hot beverages, sunlight, spicy foods, strenuous exercise, and hormonal factors. [3] [4] [5] [6] [7] [8] The reported direction and magnitude of the association between the risk of rosacea and caffeine and coffee intake in prior epidemiologic studies have been inconsistent. [8] [9] [10] [11] Previous studies did not differentiate between caffeinated and decaffeinated coffee and other beverages, and the distinction between amounts of caffeine and coffee consumed was made in only 1 study. 8 We conducted the first large cohort study to our knowledge to evaluate the association between caffeine intake, coffee consumption, and risk of incident rosacea in a large cohort of women from the Nurses' Health Study II (NHS II).
Methods

Study Population
Details of NHS II have been described previously. 12, 13 The study was approved by the institutional review board of Brigham and Women's Hospital and Harvard School of Public Health, Boston, Massachusetts. Participants' completion and return of the questionnaires were considered informed consent.
In the cohort, participants were asked about their intake of food and beverages every 4 years. Participants could report the number of servings by selecting from 9 frequency responses (never, 1-3/mo, 1/wk, 2-4/wk, 5-6/week, 1/d, 2-3/d, 4-5/d, and 6/d) for caffeinated coffee, decaffeinated coffee, tea, soft drinks, and chocolate. The total caffeine intake was calculated by summing the caffeine content for a determined amount of each item and multiplying that by its frequency of intake, for which the methods have been detailed previously. 14 Food frequency questionnaires have high reproducibility and validity, with strong correlations with multiple dietary records for coffee (r = 0.78) and other caffeine-rich beverage intake (tea, r = 0.93; caffeinated carbonated beverages, r = 0.84). 15, 16 In 2005, NHS II participants were asked if they had cliniciandiagnosed rosacea, and, if so, the year of diagnosis in 5 time intervals (before 1991, 1991-1994, 1995-1998, 1999-2002, or 2003-2005) . We recently reviewed the medical records of 16 participants who reported a diagnosis of rosacea in 2005, 14 of whom had information on rosacea in their medical records. The diagnosis of rosacea was confirmed in 12 of 14 cases. In a separate clinic-based validation study (unpublished data, W.-Q.L., June 1, 2018), the rosacea assessment question used in NHS II was validated ("Have you ever had clinician-diagnosed rosacea?"); in 37 patients with confirmed rosacea and 18 patients without rosacea, comparison between medical record diagnosis and self-reported rosacea yielded a sensitivity of 89%, a specificity of 92%, and a positive predictive value of 94%, which, though obtained from a different population, lends support to the validity of rosacea diagnosis in NHS II.
Statistical Analysis
A total of 82 737 participants responded to the question regarding a diagnosis of rosacea in 2005 and were included in the final analysis. Person-years were calculated from the return date of the 1991 questionnaire to the date of diagnosis of rosacea or end of follow-up in June 2005, whichever came first. To estimate long-term intake of caffeine, caffeinated coffee, decaffeinated coffee, and other food and drinks containing caffeine, updated cumulative averages for intake were used from all available frequency questionnaires from different years.
We conducted Cox proportional hazards analyses to estimate age-and multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of incident rosacea associated with caffeine intake and coffee consumption. For these analyses, caffeine intake was categorized as quintiles, with cutoffs derived from caffeine intake in 1991 in NHS II. Coffee consumption was categorized a priori into 5 serving groups (<1/mo, 1/mo to 4/wk, 5-7/wk, 2-3/d, or ≥4/d). Caffeine intake from coffee and caffeine intake from other food sources were assessed as continuous variables. Trend tests were carried out using continuous measures by assigning the median to each category. The adjusted Cox proportional hazard analyses were fitted to a restricted cubic spline model to obtain the HR of rosacea as a function of caffeine intake with adjustment for covariates.
We conducted stratified analyses by smoking status, alcohol intake, body mass index (BMI, calculated as weight in kilograms divided by height in meters squared), and physical activity, as well as interaction analyses between these factors and the main exposure because they have been associated with rosacea in prior studies. 11, [17] [18] [19] A 4-year lag analysis excluding rosacea cases documented within the first 4 years of each updated assessment of caffeine and coffee intake was performed to address potential reverse-causation bias. To address the concern of potential residual confounding, we conducted a sensitivity analysis additionally adjusting for oral contraceptive use, cumulative UV (UV) flux, personal history of major chronic diseases, antidepressant medication use, and phobic anxiety. Because rosacea epidemiology varies with respect to race, 20 a secondary sensitivity analysis was performed excluding nonwhite participants. All statistical analyses were conducted using SAS software, version 9.4. All statistical tests were 2-tailed with a significance level of P < .05. Table 1 summarizes the participant characteristics in 1991 stratified by quintile of caffeine intake. The proportion of current and past smokers and users of oral contraceptives were increased with increasing caffeine intake. In addition, participants with higher caffeine intake tended to be older and have higher alcohol intake. Other characteristics were similar among the 5 groups of caffeine intake. The biggest source of caffeine was caffeinated coffee, which showed the greatest difference in intake across quintiles of overall caffeine intake among the investigated food and drink groups.
Results
During the 1 120 051 person-years of follow-up, we identified 4945 incident cases of rosacea. As supported by the data 
Caffeine from coffee, mean (SD), mg/d reported in Table 2 , We found a significant inverse association between increased caffeine intake and risk of rosacea. From the lowest to highest quintile of caffeine intake, the cohort age-adjusted incidence rates (AAIRs) of rosacea were 504, 502, 501, 478, and 372 per 100 000 person-years, respectively. Compared with the lowest quintile, the absolute risks of rosacea were decreased by 2, 3, 26, and 132 per 100 000 person-years, respectively, for the second to fifth quintile. The multivariate-adjusted HRs (95% CIs) for rosacea from the lowest to highest quintiles of caffeine intake were 1 [reference], 0.91 (0.84-1.00), 0.92 (0.84-1.00), 0.85 (0.77-0.93), and 0.76 (0.69-0.84) (P < .001 for trend). The approximately linear downwardsloping restricted cubic spline curve (eFigure 1 in the Supplement) demonstrates the inverse association between caffeine intake and the risk of rosacea. As supported by the data reported in Table 3 , a significant inverse association was also observed between caffeinated coffee consumption and risk of incident rosacea (P < .001 for trend). Compared with individuals who consumed less than 1 serving of caffeinated coffee per month (AAIR, 495/100 000 person-years), participants who consumed 4 servings per day or more had the lowest risk of rosacea (AAIR, 364/100 000 person-years; HR = 0.77; 95% CI, 0.69-0.87). Decaffeinated coffee consumption was not associated with a decreased risk of rosacea (P = .39 for trend).
The data reported in Table 4 supports the association of caffeine intake with incident rosacea based on the caffeine source. Caffeine intake from coffee was inversely associated with risk of incident rosacea (P < .001 for trend), whereas caffeine intake from other sources (tea, soda, and chocolate) showed no association with risk of rosacea (P = .58 for trend).
We further examined the risk of rosacea associated with servings of caffeinated tea, caffeinated soda, and chocolate, and these data are reported in eTable 1 in the Supplement. We did not find a significant association between caffein- ated tea or soda and risk of rosacea (P = .30 for trend and P = .08 for trend, respectively). Results suggested chocolate as a potential risk factor for rosacea (P = .04 for trend) (eTable 1 in the Supplement). Analyses stratified by smoking, alcohol intake, physical activity, and BMI showed generally similar associations between caffeine intake and risk of rosacea as detailed with supporting data in eTables 2 through 5 in the Supplement. We did not find effect modification by smoking status (P =.37 for interaction), alcohol intake (P = .13 for interaction), physical activity (P = .33 for interaction), or BMI (P = .61 for interaction) on the association between caffeine intake and risk of rosacea.
The 4-year lag analysis and sensitivity analyses did not change the results materially (data not shown).
Discussion
In the present study, we found that caffeine intake from coffee but not from other foods (tea, soda, and chocolate) was associated with a decreased risk of incident rosacea in a dosedependent manner. Although the relative risk of rosacea associated with caffeine intake and caffeinated coffee consumption was moderate, the absolute risk of rosacea was decreased remarkably by 132 per 100 000 person-years for the highest vs lowest quintile of caffeine intake and 131 per 100 000 person-years for caffeinated coffee consumption of 4 servings per day or more vs less than 1 serving per month.
Previous case-control studies and review articles have asserted differing effects of caffeine intake or coffee consumption on the risk of rosacea. [8] [9] [10] [11] One case-control study from Estonia 9 and a literature review from France 10 found no significant difference in risk of rosacea between groups consuming different amounts of caffeine. A case-control study from Poland reported increased risk of rosacea among coffee drinkers. 11 In addition, a clinical narrative review and randomized clinical study analyzed caffeine as a potential trigger for rosacea flares. 3, 8 In the randomized clinical trial, 8 participants with rosacea consumed caffeinated coffee and water at different temperatures. Caffeinated coffee was shown to have no effect on flushing in patients with rosacea, whereas heat led to flushing reactions. 8 A variety of specific agents and mechanisms may be responsible for caffeine's influence on rosacea. One possibility is its effect on vascular contractility. Specifically, vasodilation from neurovascular dysfunction has been documented in the pathogenesis of rosacea, particularly papulopustular rosacea, 21,22 and caffeine is known to lead to vasoconstriction 23,24 through its effect on the renin-angiotensin-aldosterone system. 25 Increased caffeine intake may decrease vasodilation and consequently lead to diminution of rosacea symptoms. Second, caffeine has been documented to contain antioxidant agents and to have immunosuppressant effects, 26-30 which may result in decreased inflammation in rosacea. Third, hormonal factors have been implicated in the development of rosacea, [5] [6] [7] and caffeine can modulate hormone levels, including levels of adrenaline, noradrenaline, and cortisol.
25
Heat has been shown to be a trigger factor in patients with rosacea. 8 That decaffeinated coffee showed no association suggests that ingredients other than caffeine may have counteracted the effects of heat. One potential ingredient is polyphenol present in coffee. Polyphenols have antioxidant, antiinflammatory, and vascular effects, 31 and they have been shown benefit in rosacea treatment, especially for facial erythema, papules, and pustules. 31 Further studies are needed to elucidate determinants for risk of rosacea in decaffeinated coffee. We hypothesize that the lack of association with rosacea found for caffeinated food and drinks other than coffee is due to the low absolute intake of caffeine from sources other than coffee. For the different quintiles of total caffeine intake, the tea, soda, and chocolate consumption amounts did not show an increasing trend, illustrating the dominance of coffee as a source of caffeine. An alternative explanation is that coffee may contain other compounds that lower the risk of rosacea. However, since no association was found with decaffeinated coffee consumption, caffeine is the putative component of coffee responsible for the inverse association between coffee and risk of rosacea.
The positive association found between chocolate consumption and risk of rosacea has a few possible explanations. First, the amount of caffeine per serving of chocolate varies widely.
32,33 Second, chocolate itself may be a risk factor for rosacea. 34 Because the caffeine content in chocolate is low, other compounds may be responsible for the observed association.
Limitations
We acknowledge some limitations. First, data on lifetime diagnosis of rosacea and diagnosis year were self-reported in 2005 by participants, leaving our study prone to recall bias. However, misclassification of rosacea would be expected to be nondifferential with respect to caffeine and coffee intake. Our lag analysis limits the impact of misclassification of year of diagnosis. The validation study based on medical record review and the clinic-based validation study provide some support for the validity of the rosacea self-reports (unpublished data, W.-Q.L., June 1, 2018). However, we were only able to review the medical records for a small subset of cases to verify the accuracy of self-reported rosacea in the cohort. Efforts are warranted to better assess the accuracy of self-reported rosacea in the cohort. Second, caffeine intake, consumption of coffee and other beverages, was assessed in 4-year intervals. Third, etiologic heterogeneity may underlie different types of rosacea, 1 but
we did not have data on rosacea subtypes. Fourth, although we had detailed data on many covariates, we cannot rule out the possibility of residual confounding from unmeasured confounders (such as family history, stress, heat, and hot beverages) or imperfectly measured confounders (as were adjusted for in our analyses). Compounds other than caffeine in the food and drinks investigated may influence risk of rosacea. Fifth, all participants were well-educated women, and most were white, which limits the generalizability of our findings.
Conclusions
In summary, we provide evidence that caffeine intake and caffeinated coffee consumption are associated with a decreased risk of incident rosacea. Our study may have implications for the causes of and clinical approach to rosacea. Our findings do not support limiting caffeine intake as a preventive strategy for rosacea. Further studies are required to explain the underlying mechanisms of observed associations and to explore the relationship of caffeine with rosacea subtypes. © 2018 American Medical Association. All rights reserved.
a Adjusted for age (continuous variable), race (non-Hispanic white, African-American, Asian, or other race), postmenopausal hormone use (premenopause, never, current or past users), alcohol drinking (none, <4.9, 5.0-9.9, 10-14.9, 15-29.9, or ≥30.0 g/day), smoking status (never smokers, past smokers 1-4, past smokers 5-14, past smokers 15-24, past smokers ≥25, current smokers 1-4, current smokers 5-14, current smokers 15-24, current smokers ≥25 cigarettes/day), body mass index (continuous variable), and physical activity (metabolic equivalent in quintiles, h/wk). b The category of "≥4 servings/d" has been combined with the category of "2-3 servings /d" as number of cases are zero for the category of "≥4 servings/d".
c The incidence rate of rosacea adjusted to the age distribution in the Nurses' Health Study II. postmenopausal hormone use (premenopause, never, current or past users), alcohol drinking (none, <4.9, 5.0-9.9, 10-14.9, 15-29.9, or ≥30.0 g/day), smoking status (never smokers, past smokers 1-4, past smokers 5-14, past smokers 15-24, past smokers ≥25, current smokers 1-4, current smokers 5-14, current smokers 15-24, current smokers ≥25 cigarettes/day), and body mass index (continuous variable).
